Concepts (327)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Plasmodium falciparum | 24 | 2024 | 1741 | 1.740 |
Why?
|
Malaria, Falciparum | 12 | 2024 | 1075 | 1.380 |
Why?
|
Lassa Fever | 8 | 2024 | 97 | 1.250 |
Why?
|
Genome, Viral | 14 | 2022 | 673 | 1.160 |
Why?
|
Parasites | 3 | 2023 | 160 | 1.160 |
Why?
|
Ebolavirus | 12 | 2020 | 250 | 1.150 |
Why?
|
Selection, Genetic | 15 | 2014 | 877 | 1.120 |
Why?
|
Malaria | 9 | 2024 | 1241 | 1.030 |
Why?
|
Hemorrhagic Fever, Ebola | 11 | 2020 | 424 | 0.960 |
Why?
|
Genetics, Population | 7 | 2015 | 942 | 0.790 |
Why?
|
Lassa virus | 7 | 2024 | 99 | 0.740 |
Why?
|
Senegal | 12 | 2024 | 255 | 0.700 |
Why?
|
Disease Outbreaks | 15 | 2023 | 1762 | 0.640 |
Why?
|
Parasitology | 1 | 2018 | 28 | 0.610 |
Why?
|
Haploidy | 1 | 2018 | 127 | 0.600 |
Why?
|
Genome, Protozoan | 6 | 2017 | 153 | 0.530 |
Why?
|
Drug Resistance | 6 | 2024 | 1595 | 0.530 |
Why?
|
Genetic Variation | 20 | 2021 | 6606 | 0.460 |
Why?
|
DNA Barcoding, Taxonomic | 4 | 2020 | 134 | 0.450 |
Why?
|
Antimalarials | 6 | 2024 | 908 | 0.440 |
Why?
|
Phylogeny | 12 | 2021 | 2843 | 0.390 |
Why?
|
Genotype | 15 | 2024 | 13042 | 0.390 |
Why?
|
Polymorphism, Single Nucleotide | 20 | 2024 | 16028 | 0.360 |
Why?
|
Genomics | 8 | 2022 | 5916 | 0.320 |
Why?
|
Genome, Human | 9 | 2013 | 4450 | 0.310 |
Why?
|
Nigeria | 9 | 2023 | 779 | 0.300 |
Why?
|
Babesia microti | 2 | 2019 | 31 | 0.290 |
Why?
|
Models, Genetic | 6 | 2017 | 3442 | 0.280 |
Why?
|
Babesiosis | 2 | 2019 | 92 | 0.270 |
Why?
|
Haplotypes | 11 | 2024 | 2724 | 0.270 |
Why?
|
Evolution, Molecular | 7 | 2021 | 1893 | 0.260 |
Why?
|
Plasmodium vivax | 2 | 2020 | 202 | 0.260 |
Why?
|
Malaria, Vivax | 2 | 2020 | 166 | 0.260 |
Why?
|
DNA, Protozoan | 3 | 2017 | 228 | 0.240 |
Why?
|
RNA, Viral | 4 | 2019 | 2866 | 0.240 |
Why?
|
Protozoan Proteins | 3 | 2024 | 844 | 0.230 |
Why?
|
Superinfection | 1 | 2024 | 63 | 0.220 |
Why?
|
Borrelia | 1 | 2024 | 66 | 0.220 |
Why?
|
Cambodia | 3 | 2018 | 185 | 0.220 |
Why?
|
Virus Diseases | 2 | 2021 | 723 | 0.210 |
Why?
|
Molecular Epidemiology | 6 | 2022 | 473 | 0.210 |
Why?
|
Malaria Vaccines | 1 | 2024 | 164 | 0.210 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2023 | 168 | 0.200 |
Why?
|
Genetic Techniques | 2 | 2016 | 428 | 0.190 |
Why?
|
Recombination, Genetic | 6 | 2014 | 1526 | 0.190 |
Why?
|
Chromosomes, Human, X | 1 | 2004 | 320 | 0.190 |
Why?
|
Africa | 7 | 2022 | 726 | 0.190 |
Why?
|
Ghana | 2 | 2024 | 319 | 0.190 |
Why?
|
Genetic Fitness | 1 | 2022 | 120 | 0.180 |
Why?
|
Plasmodium | 1 | 2024 | 248 | 0.180 |
Why?
|
Mumps virus | 1 | 2020 | 23 | 0.170 |
Why?
|
Virus Release | 1 | 2020 | 35 | 0.170 |
Why?
|
Nucleocapsid Proteins | 1 | 2020 | 75 | 0.170 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 192 | 0.170 |
Why?
|
Linkage Disequilibrium | 8 | 2012 | 1998 | 0.170 |
Why?
|
Viruses | 1 | 2023 | 373 | 0.170 |
Why?
|
Yellow Fever | 1 | 2020 | 54 | 0.170 |
Why?
|
Biological Evolution | 7 | 2021 | 1078 | 0.160 |
Why?
|
Body Temperature Regulation | 1 | 2021 | 292 | 0.160 |
Why?
|
Metagenomics | 2 | 2023 | 475 | 0.160 |
Why?
|
Mumps | 1 | 2020 | 71 | 0.160 |
Why?
|
Metagenome | 2 | 2020 | 465 | 0.160 |
Why?
|
Mutation | 14 | 2024 | 30228 | 0.160 |
Why?
|
Pneumonia, Bacterial | 1 | 2021 | 319 | 0.160 |
Why?
|
Computer Systems | 1 | 2020 | 470 | 0.150 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 365 | 0.150 |
Why?
|
Markov Chains | 3 | 2018 | 977 | 0.150 |
Why?
|
Africa, Western | 4 | 2021 | 160 | 0.140 |
Why?
|
Population Density | 2 | 2014 | 193 | 0.140 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2018 | 308 | 0.130 |
Why?
|
Sequence Analysis, RNA | 3 | 2019 | 2038 | 0.130 |
Why?
|
Gene Frequency | 8 | 2014 | 3617 | 0.130 |
Why?
|
Gene Dosage | 2 | 2018 | 1221 | 0.130 |
Why?
|
Humans | 71 | 2024 | 768393 | 0.130 |
Why?
|
Rhabdoviridae | 1 | 2015 | 5 | 0.130 |
Why?
|
Rhabdoviridae Infections | 1 | 2015 | 9 | 0.120 |
Why?
|
Genetic Loci | 4 | 2012 | 2630 | 0.120 |
Why?
|
Disaster Planning | 1 | 2021 | 560 | 0.120 |
Why?
|
Genes, Protozoan | 2 | 2012 | 170 | 0.120 |
Why?
|
Artemisinins | 1 | 2017 | 217 | 0.120 |
Why?
|
Pandemics | 4 | 2022 | 8753 | 0.120 |
Why?
|
Sierra Leone | 4 | 2015 | 171 | 0.120 |
Why?
|
Gene Conversion | 1 | 2014 | 69 | 0.120 |
Why?
|
Algorithms | 2 | 2014 | 14154 | 0.110 |
Why?
|
Sequence Analysis, DNA | 6 | 2020 | 4775 | 0.110 |
Why?
|
Amino Acids | 1 | 2020 | 1716 | 0.110 |
Why?
|
Vagina | 1 | 2019 | 845 | 0.110 |
Why?
|
Hemorrhagic Fevers, Viral | 1 | 2012 | 23 | 0.100 |
Why?
|
Viral Envelope Proteins | 1 | 2016 | 641 | 0.100 |
Why?
|
Quinolines | 1 | 2018 | 768 | 0.100 |
Why?
|
Gambia | 1 | 2012 | 104 | 0.100 |
Why?
|
Population Groups | 2 | 2010 | 208 | 0.100 |
Why?
|
Demography | 2 | 2014 | 1642 | 0.100 |
Why?
|
Principal Component Analysis | 2 | 2012 | 948 | 0.100 |
Why?
|
Genes, Reporter | 1 | 2016 | 1524 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1468 | 0.100 |
Why?
|
Access to Information | 1 | 2015 | 317 | 0.100 |
Why?
|
Animals | 21 | 2023 | 169337 | 0.100 |
Why?
|
Zoonoses | 3 | 2018 | 180 | 0.100 |
Why?
|
Epidemics | 2 | 2014 | 517 | 0.100 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2429 | 0.100 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 605 | 0.090 |
Why?
|
Disease Reservoirs | 3 | 2018 | 123 | 0.090 |
Why?
|
Chromosomes | 1 | 2014 | 579 | 0.090 |
Why?
|
Chromosome Mapping | 4 | 2015 | 4622 | 0.090 |
Why?
|
Communicable Diseases, Emerging | 1 | 2012 | 148 | 0.090 |
Why?
|
Malaria, Cerebral | 1 | 2012 | 136 | 0.090 |
Why?
|
Contact Tracing | 2 | 2022 | 275 | 0.080 |
Why?
|
Fever | 3 | 2024 | 1620 | 0.080 |
Why?
|
Genetic Markers | 3 | 2019 | 2604 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2533 | 0.080 |
Why?
|
Genome-Wide Association Study | 5 | 2024 | 12778 | 0.080 |
Why?
|
Seroepidemiologic Studies | 2 | 2024 | 405 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1515 | 0.070 |
Why?
|
Receptors, Virus | 2 | 2021 | 648 | 0.070 |
Why?
|
Software | 3 | 2018 | 4453 | 0.070 |
Why?
|
Cholera | 1 | 2013 | 754 | 0.070 |
Why?
|
Pneumonia, Viral | 2 | 2021 | 3241 | 0.070 |
Why?
|
DNA Copy Number Variations | 2 | 2018 | 2046 | 0.070 |
Why?
|
Information Dissemination | 1 | 2015 | 1137 | 0.070 |
Why?
|
Virion | 2 | 2020 | 430 | 0.070 |
Why?
|
Base Sequence | 5 | 2015 | 12422 | 0.060 |
Why?
|
Cluster Analysis | 3 | 2022 | 2728 | 0.050 |
Why?
|
Seasons | 2 | 2023 | 1526 | 0.050 |
Why?
|
Chromosomes, Human, Y | 1 | 2004 | 163 | 0.050 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2021 | 792 | 0.050 |
Why?
|
Antibodies, Viral | 3 | 2020 | 3211 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11918 | 0.050 |
Why?
|
Bayes Theorem | 2 | 2022 | 2353 | 0.050 |
Why?
|
Amino Acid Substitution | 2 | 2016 | 1742 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7955 | 0.050 |
Why?
|
Kenya | 1 | 2024 | 757 | 0.050 |
Why?
|
South America | 2 | 2015 | 180 | 0.050 |
Why?
|
HIV-1 | 1 | 2019 | 6963 | 0.050 |
Why?
|
Ectoderm | 1 | 2021 | 138 | 0.050 |
Why?
|
Eccrine Glands | 1 | 2021 | 52 | 0.050 |
Why?
|
Geography | 2 | 2017 | 654 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2020 | 4291 | 0.050 |
Why?
|
Polymorphism, Genetic | 3 | 2021 | 4250 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2003 | 877 | 0.040 |
Why?
|
Sri Lanka | 1 | 2020 | 93 | 0.040 |
Why?
|
Viral Proteins | 2 | 2020 | 1802 | 0.040 |
Why?
|
Bystander Effect | 1 | 2020 | 89 | 0.040 |
Why?
|
Sweating | 1 | 2021 | 155 | 0.040 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2021 | 167 | 0.040 |
Why?
|
Myelopoiesis | 1 | 2020 | 135 | 0.040 |
Why?
|
Asia | 2 | 2015 | 627 | 0.040 |
Why?
|
Zambia | 1 | 2020 | 273 | 0.040 |
Why?
|
Virus Assembly | 1 | 2020 | 141 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3464 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2016 | 3666 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 326 | 0.040 |
Why?
|
Phylogeography | 1 | 2018 | 72 | 0.040 |
Why?
|
Computer Simulation | 4 | 2005 | 6277 | 0.040 |
Why?
|
Infant | 4 | 2024 | 36510 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2024 | 1034 | 0.040 |
Why?
|
Female | 15 | 2024 | 397089 | 0.040 |
Why?
|
Vaccination | 2 | 2021 | 3431 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2004 | 871 | 0.040 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2020 | 435 | 0.040 |
Why?
|
Limit of Detection | 1 | 2019 | 276 | 0.040 |
Why?
|
Incidence | 3 | 2024 | 21544 | 0.040 |
Why?
|
Male | 14 | 2024 | 364902 | 0.040 |
Why?
|
Honduras | 1 | 2017 | 39 | 0.040 |
Why?
|
Child | 6 | 2022 | 80891 | 0.040 |
Why?
|
Genetic Linkage | 2 | 2013 | 2342 | 0.030 |
Why?
|
Cheirogaleidae | 1 | 2016 | 9 | 0.030 |
Why?
|
Universities | 1 | 2022 | 1005 | 0.030 |
Why?
|
Rodentia | 1 | 2018 | 262 | 0.030 |
Why?
|
Thailand | 1 | 2017 | 288 | 0.030 |
Why?
|
Caribbean Region | 1 | 2017 | 193 | 0.030 |
Why?
|
Culicidae | 1 | 2017 | 110 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 716 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2020 | 993 | 0.030 |
Why?
|
Callithrix | 1 | 2016 | 95 | 0.030 |
Why?
|
Keratinocytes | 1 | 2021 | 876 | 0.030 |
Why?
|
Atovaquone | 1 | 2016 | 56 | 0.030 |
Why?
|
Cytochromes b | 1 | 2016 | 35 | 0.030 |
Why?
|
Child, Preschool | 4 | 2022 | 42650 | 0.030 |
Why?
|
Colombia | 1 | 2017 | 287 | 0.030 |
Why?
|
Quantitative Trait Loci | 2 | 2016 | 2127 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2020 | 1438 | 0.030 |
Why?
|
Aedes | 1 | 2017 | 101 | 0.030 |
Why?
|
Climate | 1 | 2017 | 147 | 0.030 |
Why?
|
Species Specificity | 1 | 2020 | 2417 | 0.030 |
Why?
|
Puerto Rico | 1 | 2017 | 380 | 0.030 |
Why?
|
Liberia | 1 | 2016 | 176 | 0.030 |
Why?
|
Murinae | 1 | 2015 | 18 | 0.030 |
Why?
|
Florida | 1 | 2017 | 430 | 0.030 |
Why?
|
Homozygote | 3 | 2007 | 1779 | 0.030 |
Why?
|
Guinea | 1 | 2015 | 33 | 0.030 |
Why?
|
Models, Molecular | 2 | 2020 | 5404 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2016 | 378 | 0.030 |
Why?
|
United States | 5 | 2023 | 73150 | 0.030 |
Why?
|
Azithromycin | 1 | 2016 | 200 | 0.030 |
Why?
|
Virology | 1 | 2015 | 76 | 0.030 |
Why?
|
Spondylitis, Ankylosing | 1 | 2016 | 159 | 0.030 |
Why?
|
NF-kappa B | 2 | 2013 | 2489 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2021 | 1368 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2007 | 4414 | 0.030 |
Why?
|
Databases, Nucleic Acid | 1 | 2015 | 204 | 0.030 |
Why?
|
Ribosomal Proteins | 1 | 2016 | 370 | 0.030 |
Why?
|
RNA Viruses | 1 | 2015 | 111 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2020 | 2362 | 0.030 |
Why?
|
Immunity, Innate | 1 | 2005 | 3078 | 0.030 |
Why?
|
Isoenzymes | 1 | 2018 | 1684 | 0.030 |
Why?
|
Gene Library | 1 | 2016 | 1061 | 0.030 |
Why?
|
Primate Diseases | 1 | 2012 | 15 | 0.030 |
Why?
|
Alleles | 3 | 2016 | 6892 | 0.030 |
Why?
|
Rivers | 1 | 2013 | 65 | 0.030 |
Why?
|
South Africa | 1 | 2019 | 1871 | 0.030 |
Why?
|
Toll-Like Receptor 5 | 1 | 2013 | 42 | 0.030 |
Why?
|
Multilocus Sequence Typing | 1 | 2013 | 102 | 0.030 |
Why?
|
Brazil | 1 | 2017 | 1248 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2726 | 0.030 |
Why?
|
Virulence | 1 | 2016 | 1298 | 0.030 |
Why?
|
Protein Conformation | 1 | 2020 | 3955 | 0.030 |
Why?
|
Regression Analysis | 1 | 2022 | 6350 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1967 | 0.030 |
Why?
|
Flagellin | 1 | 2013 | 124 | 0.030 |
Why?
|
HIV Infections | 1 | 2019 | 17575 | 0.020 |
Why?
|
Base Composition | 1 | 2012 | 291 | 0.020 |
Why?
|
Adolescent | 4 | 2022 | 89184 | 0.020 |
Why?
|
Cytoplasm | 1 | 2016 | 1502 | 0.020 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2013 | 182 | 0.020 |
Why?
|
Program Evaluation | 1 | 2020 | 2505 | 0.020 |
Why?
|
Mefloquine | 1 | 2011 | 55 | 0.020 |
Why?
|
Molecular Typing | 1 | 2012 | 115 | 0.020 |
Why?
|
Internationality | 1 | 2017 | 1008 | 0.020 |
Why?
|
Parasitemia | 1 | 2012 | 165 | 0.020 |
Why?
|
Adult | 7 | 2021 | 223640 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 655 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 3 | 2014 | 18048 | 0.020 |
Why?
|
Monocytes | 1 | 2020 | 2595 | 0.020 |
Why?
|
Phenanthrenes | 1 | 2011 | 66 | 0.020 |
Why?
|
Travel | 1 | 2017 | 800 | 0.020 |
Why?
|
Malawi | 1 | 2012 | 309 | 0.020 |
Why?
|
Ethanolamines | 1 | 2011 | 153 | 0.020 |
Why?
|
Specimen Handling | 1 | 2015 | 708 | 0.020 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.020 |
Why?
|
Primates | 1 | 2012 | 521 | 0.020 |
Why?
|
Research Personnel | 1 | 2015 | 590 | 0.020 |
Why?
|
Antigens, CD | 1 | 2020 | 4031 | 0.020 |
Why?
|
Human Genome Project | 1 | 2010 | 202 | 0.020 |
Why?
|
Fluorenes | 1 | 2011 | 160 | 0.020 |
Why?
|
Anopheles | 1 | 2012 | 193 | 0.020 |
Why?
|
Africa South of the Sahara | 1 | 2012 | 751 | 0.020 |
Why?
|
Nucleotides | 1 | 2012 | 455 | 0.020 |
Why?
|
DNA, Intergenic | 1 | 2010 | 108 | 0.020 |
Why?
|
Blood | 1 | 2012 | 597 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 60049 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 81801 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8902 | 0.020 |
Why?
|
Time Factors | 3 | 2020 | 40272 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9562 | 0.020 |
Why?
|
International Cooperation | 1 | 2015 | 1438 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1397 | 0.020 |
Why?
|
Inflammasomes | 1 | 2013 | 540 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2014 | 1070 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5792 | 0.020 |
Why?
|
Edar Receptor | 1 | 2007 | 24 | 0.020 |
Why?
|
Diarrhea | 1 | 2014 | 1320 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9371 | 0.020 |
Why?
|
Glycoproteins | 1 | 2015 | 2204 | 0.020 |
Why?
|
Publishing | 1 | 2015 | 836 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14784 | 0.020 |
Why?
|
Community Health Services | 1 | 2012 | 659 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4588 | 0.020 |
Why?
|
Skin | 1 | 2021 | 4499 | 0.020 |
Why?
|
Middle Aged | 5 | 2021 | 223491 | 0.020 |
Why?
|
Vibrio cholerae | 1 | 2013 | 793 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 41795 | 0.020 |
Why?
|
Central America | 1 | 2006 | 69 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5878 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2890 | 0.020 |
Why?
|
Adaptation, Biological | 1 | 2007 | 147 | 0.020 |
Why?
|
Antiporters | 1 | 2007 | 276 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2016 | 3712 | 0.020 |
Why?
|
Prevalence | 2 | 2013 | 15872 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5796 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 12805 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7445 | 0.020 |
Why?
|
Time | 1 | 2007 | 546 | 0.020 |
Why?
|
Viral Load | 1 | 2014 | 3398 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10478 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2020 | 19022 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15455 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9510 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12092 | 0.010 |
Why?
|
Computational Biology | 2 | 2010 | 3543 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9343 | 0.010 |
Why?
|
Influenza, Human | 1 | 2015 | 1539 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8506 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9261 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2016 | 4936 | 0.010 |
Why?
|
Mortality | 1 | 2014 | 2917 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13323 | 0.010 |
Why?
|
Gene Pool | 1 | 2002 | 36 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11668 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20224 | 0.010 |
Why?
|
Internet | 1 | 2015 | 3107 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26375 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22355 | 0.010 |
Why?
|
Pan troglodytes | 1 | 2002 | 224 | 0.010 |
Why?
|
Bacteria | 1 | 2013 | 2221 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2742 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26411 | 0.010 |
Why?
|
Transcription Factors | 1 | 2021 | 12166 | 0.010 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2002 | 209 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2003 | 784 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14737 | 0.010 |
Why?
|
CD40 Ligand | 1 | 2002 | 524 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3779 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17626 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7598 | 0.010 |
Why?
|
HLA Antigens | 1 | 2003 | 1337 | 0.010 |
Why?
|
Japan | 1 | 2002 | 1418 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22296 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59686 | 0.010 |
Why?
|
China | 1 | 2002 | 2395 | 0.010 |
Why?
|
Europe | 1 | 2002 | 3439 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 54920 | 0.010 |
Why?
|
Mice | 1 | 2021 | 82017 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 65379 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23631 | 0.010 |
Why?
|
Aged | 1 | 2021 | 171562 | 0.000 |
Why?
|
Brain | 1 | 2007 | 27454 | 0.000 |
Why?
|
Concepts
(327)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(80)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_